logo BDSP

Base documentaire


  1. Chronic liver disease in Peru : role of viral hepatitis.

    Article - En anglais

    The prevalence of antibodies to hepatitis C virus (anti-HCV) was determined in 105 patients with biopsy-proven chronic liver disease and 128 comparison patients without any evidence of liver pathology living in Lima, Peru.

    Using a second-generation EIA screening and supplemental immunoblot assay, anti-HCV was detected in four of 13 patients with chronic hepatitis, in 11% of 85 patients with cirrhosis, and in none of seven patients with hepatocellular carcinoma.

    Only two (1.6%) comparison patients without liver disease had anti-HCV.

    Hepatitis B surface antigen (HBsAg) was found in 23% of patients with chronic hepatitis, 12% of patients with cirrhosis, and three of seven patients with hepato-cellular carcinoma.

    Mots-clés Pascal : Pérou, Homme, Chronique, Epidémiologie, Prévalence, Sérologie, Epithélioma, Cirrhose, Hépatite virale B, Hépatite virale C, Marqueur biologique, Antigène HBs, Etiologie, Amérique du Sud, Amérique, Appareil digestif pathologie, Foie pathologie, Virose, Infection, Tumeur maligne

    Mots-clés Pascal anglais : Peru, Human, Chronic, Epidemiology, Prevalence, Serology, Carcinoma, Cirrhosis, Viral hepatitis B, Viral hepatitis C, Biological marker, Hepatitis B surface antigen, Etiology, South America, America, Digestive diseases, Hepatic disease, Viral disease, Infection, Malignant tumor

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 94-0309824

    Code Inist : 002B30A01A2. Création : 199406.